Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution
Xiaonan Zhang(Shanghai Public Health Clinical Center), Zhenghong Yuan(Shanghai Medical College of Fudan University), Di Tian(Shanghai Public Health Clinical Center), Jialin Cai(Shanghai Jiao Tong University), Lei Xu(Shanghai Public Health Clinical Center), Hui‐Ling Yen(University of Hong Kong), Yuqin Yang(Shanghai Public Health Clinical Center), Bisheng Shi(Shanghai Public Health Clinical Center), Haili Chen(Wenzhou Medical University), Wanju Zhang(Shanghai Public Health Clinical Center), Yanmin Wan(Shanghai Medical College of Fudan University), Boyin Qin(Shanghai Public Health Clinical Center), Yi Liu(Shenyang University of Chemical Technology), Sen Wang(Fudan University), Xiaoyan Zhang(Fujian Medical University), Jianhua Li(Kunming University of Science and Technology), Lu Liu(Shanghai Public Health Clinical Center), Wenjiang Zhou(Shanghai Public Health Clinical Center), Jing He(Shanghai Public Health Clinical Center), Wencai Guan(Jinshan Hospital of Fudan University), Zhaoqin Zhu(Shanghai Medical College of Fudan University), Chunhua Xu(Chinese University of Hong Kong), Zhigang Song(Fudan University), Xiaohui Zhou(Zhongda Hospital Southeast University), Xiaonan Ren(Shanghai Public Health Clinical Center), Yunwen Hu(Southern University of Science and Technology), Jianqing Xu(Weifang Medical University), Wei Wang(Guangxi University), Malik Peiris(Biology of Infection)
Cited by 41
Related Papers
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
|Nature|2020|1.5k